We are live on
!
Find out more
CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Est. Return
8.19%
This Fund
S&P 500
This Quarter
Est. Return
-10.34%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$718M
AUM Growth
-$885M
(-55%)
Cap. Flow
-$771M
Cap. Flow
% of AUM
-107.36%
Top 10 Holdings %
Top 10 Hldgs %
78.87%
Holding
35
New
4
Increased
1
Reduced
16
Closed
9
Top Buys
| 1 |
Icon
ICLR
|
+$42.6M |
| 2 |
Merck
MRK
|
+$39.7M |
| 3 |
UnitedHealth
UNH
|
+$38.2M |
| 4 |
APLS
Apellis Pharmaceuticals
APLS
|
+$15.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$5.89M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
+$121M |
| 2 |
Humana
HUM
|
+$106M |
| 3 |
Baxter International
BAX
|
+$87.9M |
| 4 |
CVS Health
CVS
|
+$78.7M |
| 5 |
PTC Therapeutics
PTCT
|
+$76.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Structure Therapeutics
GPCR
$3.5B
| – | – |
-300,000
| Closed | -$5.19M |
|
27
GSK
GSK
$103B
| – | – |
0
| – | – |
|
28
Ionis Pharmaceuticals
IONS
$8.96B
| – | – |
-725,000
| Closed | -$21.9M |
|
29
MoonLake Immunotherapeutics
MLTX
$1.67B
| – | – |
-441,000
| Closed | -$17.2M |
|
|
30
PTC Therapeutics
PTCT
$6.49B
| – | – |
-1,500,000
| Closed | -$76.4M |
|
31
Qiagen
QGEN
$8.56B
| – | – |
-1,400,000
| Closed | -$56.2M |
|
32
State Street SPDR S&P 500 ETF Trust
SPY
$785B
| – | – |
0
| – | – |
|
33
Sarepta Therapeutics
SRPT
$1.85B
| – | – |
-800,000
| Closed | -$51.1M |
|
34
10x Genomics
TXG
$5.84B
| – | – |
-1,000,000
| Closed | -$8.73M |
|
35
State Street SPDR S&P Biotech ETF
XBI
$10.6B
| – | – |
0
| – | – |
|
Similar funds
CCP
ECM
BC
BWA
SC
TSWM
WCWM
SXL